Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Offerings

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Contracts
  • News
  • Offerings

Agrify Corporation Enters Into Agreements To Raise Up To $1.84M From The Exercise Of Previously Issued Common Stock Warrants

By Happy Mohamed
April 19, 8:21 AM
 Agrify Corporation (NASDAQ:AGFY) ("Agrify" or the "Company"), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced it has entered

AGFY

Read More
1 minute read
  • News
  • Offerings

Gamida Cell Announces Pricing Of $22.8M Public Offering Of 17.5M Shares Of Common Stock And Warrants At A Price Of $1.30/Share And Exercise price of $1.35/Warrant

By Happy Mohamed
April 19, 8:19 AM
Gamida Cell Ltd. (NASDAQ:GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the pricing of an underwritten public offering of 17,500,000 ordinary shares and accompanying

GMDA

Read More
1 minute read
  • News
  • Offerings

TELA Bio Announces Pricing Of $42.125M Public Offering Of 4.75M Shares Of Common Stock At A Price Of $9.50/Share

By Happy Mohamed
April 19, 7:18 AM
TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and

TELA

Read More
1 minute read
  • News
  • Offerings

Gamida Cell Announces Launch of Public Offering of Securities; No Size Or Amount Disclosed

By Happy Mohamed
April 19, 7:16 AM
Gamida Cell Ltd. (NASDAQ:GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the launch of a follow-on public offering of its ordinary shares and accompanying warrants to

GMDA

Read More
1 minute read
  • News
  • Offerings

Vaxcyte Raises $500M Via Secondary Stock Offering Of 11.2M Shares At $41 Per Share

By Benzinga Newsdesk
April 19, 3:21 AM
Vaxcyte, Inc. (NASDAQ:PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today the pricing of an underwritten

PCVX

Read More
1 minute read
  • News
  • Offerings

Trilogy Metals Announces $3.22M Private Placement Financing With Major Shareholders To Issues ~5,854,545 Shares Of Common Stock At A Price Of $0.55/Share

By Happy Mohamed
April 18, 4:33 PM
 Trilogy Metals Inc. (TSX:TMQ) (NYSE:TMQ) ("Trilogy" or the "Company") is pleased to announce that the Company intends to enter into a non-brokered private placement lead by its two

TMQ

Read More
1 minute read
  • News
  • Offerings

TELA Bio Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed

By Happy Mohamed
April 18, 4:11 PM
TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and

TELA

Read More
1 minute read
  • News
  • Offerings

Phio Pharmaceuticals Announces $2M Registered Direct Offering Of 353,983 Shares Of Common Stock At Price Of $5.65/Share At-The-Market Under Nasdaq Rules

By Benzinga Newsdesk
April 18, 12:23 PM
Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today

PHIO

Read More
1 minute read
  • News
  • Offerings

Immuneering Announces $30M Underwritten Offering Of 2,727,273 Shares Of Common Stock At A Price Of $11/Share

By Happy Mohamed
April 18, 9:28 AM
Immuneering Corporation (NASDAQ:IMRX) ("Immuneering"), a clinical-stage oncology company developing medicines for broad populations of cancer patients with an initial aim to develop a universal-RAS therapy,

IMRX

Read More
1 minute read
  • Equities
  • General
  • Markets
  • News
  • Offerings

Enovix Raises $150M Via Debt Offering

By Shivani Kumaresan
April 18, 9:18 AM
Enovix Corp (NASDAQ:ENVX) has priced its $150.0 million of 3.00% Convertible Senior Notes due 2028 in a private placement. An…

ENVX

Posts pagination

Previous 1 … 80 81 82 … 166 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service